Since our main interest was to explore the relationships between PSCI and neuroinflammation on 18F-THK-5351 PET imaging, we only enrolled amyloid-negative stroke patients without tauopathy presentations to reduce the possibility of 18F-THK-5351 binding to tau protein. This evidence concerns the gene MAPT and tauopathy.